Literature DB >> 18356391

Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?

Anna C Bibby, Anna Farrell, Michelle Cummins, Michel Erlewyn-Lajeunesse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18356391     DOI： 10.1136/adc.2007.132340

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  4 in total

Review 1.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Vaccine administration and the development of immune thrombocytopenic purpura in children.

Authors:  Valerio Cecinati; Nicola Principi; Letizia Brescia; Paola Giordano; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

3.  COVID-19 vaccination associated severe immune thrombocytopenia.

Authors:  Syed Raza Ali Shah; Sherpa Dolkar; Jacob Mathew; Prakash Vishnu
Journal:  Exp Hematol Oncol       Date:  2021-07-15

Review 4.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.